Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001288 · ClinicalTrials.gov registry record
Brain Blood Flow Studies of Language and Memory
A clinical trial of Epilepsy and Cerebrovascular Disorder, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- 303
- Enrollment target
- 1
- Study location
NCT00001288 is a study of Epilepsy and Cerebrovascular Disorder that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 303 participants, below the 951-participant average among 160 other Epilepsy trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00001288, a study of Epilepsy and Cerebrovascular Disorder, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- 303 participants
- Enrollment target
- 1
- Study location
Study Summary
Positron Emission Tomography (PET) is a technique used to investigate the functional activity of the brain. The PET technique allows doctors to study the normal processes of the brain (central nervous system) of normal individuals and patients with neurologic illnesses without physical / structural damage to the brain. When a region of the brain is active, it uses more fuel in the form of oxygen and sugar (glucose). As the brain uses more fuel it produces more waste products, carbon dioxide and water. Blood carries fuel to the brain and waste products away from the brain. As brain activity increases blood flow to and from the area of activity increases also. Knowing these facts, researchers can use radioactive water (H215O) and PET scans to observe what areas of the brain are receiving more blood flow. This study is designed to use positron emission tomography (PET) with radioactive water (H215O) to determine the areas of the brain associated with memory and language. Patients participating in the study will be made up of normal volunteers, patients with epilepsy, and patients with other abnormalities related to the surface of the brain (non-epileptic focal cortical dysfunctions).
Conditions Studied
Interventions
- DRUG FDG
- DRUG 15 O Water
Study Locations (1)
Maryland
- National Institute of Neurological Disorders and Stroke (NINDS) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 1991-05 |
| Est. Completion | 2003-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001288
The ClinicalTrials.gov registry entry for NCT00001288 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 303 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 951-participant average among 160 other Epilepsy trials with a reported enrollment target (68% lower). The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Epilepsy appearing as the primary indexed condition, and to 2 interventions - of which FDG is the first listed.
NCT00001288 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001288 about?
NCT00001288 is a clinical study titled "Brain Blood Flow Studies of Language and Memory". Positron Emission Tomography (PET) is a technique used to investigate the functional activity of the brain. The PET technique allows doctors to study the normal processes of the brain (central nervous system) of normal individuals and patients with neurologic illnesses without physical / structural ...
What is the current status of trial NCT00001288?
This trial is currently completed. The enrollment target is 303 participants. The study started on 1991-05. Estimated completion is 2003-06.
What conditions does trial NCT00001288 study?
This clinical trial studies the following conditions: Epilepsy, Cerebrovascular Disorder.
What interventions are being tested in trial NCT00001288?
The interventions under investigation include: FDG (DRUG), 15 O Water (DRUG).
Who is sponsoring clinical trial NCT00001288?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001288 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.